Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2017 Filed Jun 2, 2017 01:38 UTC |
Gross Jane ASee Remarks
|
GrantEmployee Stock Option (right to buy) · Derivative | 33,700 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000544 · gross_4.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,700 Underlying: Common Stock · 33,700 shares Expires 2027-05-31 F1 · date: The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 21:40 UTC |
Maddux Randy JoeSenior VP, Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 33,700 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000548 · maddux_4.xml · derivative · entry 1 Maddux Randy Joe · CIK 0001683826 · Senior VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,700 Underlying: Common Stock · 33,700 shares Expires 2027-05-31 F1 · date: The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:42 UTC |
White Marvin LDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,800 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000551 · white_4.xml · derivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,800 Underlying: Common Stock · 75,800 shares Expires 2027-05-31 F1 · date: The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:41 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
GrantEmployee Stock Option (right to buy) · Derivative | 33,700 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000550 · stromatt_4.xml · derivative · entry 1 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,700 Underlying: Common Stock · 33,700 shares Expires 2027-05-31 F1 · date: The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:41 UTC |
Niederhuber JohnDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000549 · niederhuber_4.xml · derivative · entry 1 Niederhuber John · CIK 0001501240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:39 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 33,700 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000547 · lamothe_4.xml · derivative · entry 1 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,700 Underlying: Common Stock · 33,700 shares Expires 2027-05-31 F1 · date: The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017. F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:39 UTC |
Kunz Barbara LopezDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000546 · kunz_4.xml · derivative · entry 1 Kunz Barbara Lopez · CIK 0001679970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:38 UTC |
Harsanyi ZsoltDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000545 · harsanyi_4.xml · derivative · entry 1 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:37 UTC |
Grant Grady IIIDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000543 · grant_4.xml · derivative · entry 1 Grant Grady III · CIK 0001679966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:36 UTC |
El-Hibri FuadDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000542 · elhibri_4.xml · derivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 01:36 UTC |
Abdun-Nabi DanielDirector
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001019056-17-000541 · abdunnabi_4.xml · derivative · entry 1 Abdun-Nabi Daniel · CIK 0001380187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018. Read SEC document |
| May 22, 2017 Filed May 23, 2017 21:36 UTC |
White Marvin LDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 17,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000493 · white_4.xml · derivative · entry 4 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,644 Underlying: Common Stock · 17,828 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs were originally issued by Emergent on May 22, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on May 22, 2017. F3 · derivative.expiration_date: The RSUs were originally issued by Emergent on May 22, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on May 22, 2017. Read SEC document |
| May 22, 2017 Filed May 23, 2017 21:36 UTC |
White Marvin LDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 35,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000493 · white_4.xml · derivative · entry 3 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,472 Underlying: Common Stock · 35,643 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on May 21, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on May 21, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| May 22, 2017 Filed May 23, 2017 21:36 UTC |
White Marvin LDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,828 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000493 · white_4.xml · nonDerivative · entry 2 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| May 22, 2017 Filed May 23, 2017 21:36 UTC |
White Marvin LDirector · President and CEO
|
Exercise / conversionCommon Stock | 35,643 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000493 · white_4.xml · nonDerivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 14,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · derivative · entry 9 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,235 Underlying: Common Stock · 14,506 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017. F4 · derivative.expiration_date: The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Tax withholdingCommon Stock | 3,837 | $1.78 | $6,829.86 |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · nonDerivative · entry 6 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,416 Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionCommon Stock | 14,506 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · nonDerivative · entry 5 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 18,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · derivative · entry 9 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,725 Underlying: Common Stock · 18,863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017. F4 · derivative.expiration_date: The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · derivative · entry 8 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,588 Underlying: Common Stock · 6,746 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 6,746 on March 10, 2017 and 6,747 on March 10, 2018. F3 · derivative.expiration_date: The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 6,746 on March 10, 2017 and 6,747 on March 10, 2018. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Tax withholdingCommon Stock | 4,990 | $1.78 | $8,882.20 |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · nonDerivative · entry 6 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,284 Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 18,863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · nonDerivative · entry 5 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Tax withholdingCommon Stock | 1,785 | $1.78 | $3,177.30 |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · nonDerivative · entry 4 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,411 Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 24,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · derivative · entry 9 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,934 Underlying: Common Stock · 24,836 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017. F4 · derivative.expiration_date: The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Tax withholdingCommon Stock | 6,570 | $1.78 | $11,694.60 |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · nonDerivative · entry 6 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,072 Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionCommon Stock | 24,836 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · nonDerivative · entry 5 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 09, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · derivative · entry 8 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,741 Underlying: Common Stock · 9,727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 9,727 on March 9, 2017 and 9,728 on March 9, 2018. F3 · derivative.expiration_date: The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 9,727 on March 9, 2017 and 9,728 on March 9, 2018. Read SEC document |
| March 09, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Tax withholdingCommon Stock | 2,573 | $1.80 | $4,631.40 |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · nonDerivative · entry 4 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,747 Read SEC document |
| March 09, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionCommon Stock | 9,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · nonDerivative · entry 3 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 09, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 13,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · derivative · entry 8 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,770 Underlying: Common Stock · 13,902 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 13,902 on March 9, 2017 and 13,892 on March 9, 2018. F3 · derivative.expiration_date: The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 13,902 on March 9, 2017 and 13,892 on March 9, 2018. Read SEC document |
| March 09, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Tax withholdingCommon Stock | 3,678 | $1.80 | $6,620.40 |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · nonDerivative · entry 4 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,806 Read SEC document |
| March 09, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionCommon Stock | 13,902 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · nonDerivative · entry 3 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · derivative · entry 7 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,468 Underlying: Common Stock · 9,140 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 9,140 on March 1, 2017, 9,140 on March 1, 2018 and 9,138 on March 1, 2019. F2 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 9,140 on March 1, 2017, 9,140 on March 1, 2018 and 9,138 on March 1, 2019. Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Tax withholdingCommon Stock | 2,148 | $2.02 | $4,338.96 |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · nonDerivative · entry 2 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,593 Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:06 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionCommon Stock | 9,140 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000290 · gross_4.xml · nonDerivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · derivative · entry 7 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,334 Underlying: Common Stock · 7,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019. F2 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019. Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 6,746 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · nonDerivative · entry 3 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Tax withholdingCommon Stock | 1,936 | $2.02 | $3,910.72 |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · nonDerivative · entry 2 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,450 Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:05 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
Exercise / conversionCommon Stock | 7,320 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000288 · lamothe_4.xml · nonDerivative · entry 1 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · derivative · entry 7 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,672 Underlying: Common Stock · 16,269 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date. F2 · derivative.expiration_date: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date. Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Tax withholdingCommon Stock | 5,312 | $2.02 | $10,730.24 |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · nonDerivative · entry 2 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,582 Read SEC document |
| March 01, 2017 Filed Mar 14, 2017 01:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
Exercise / conversionCommon Stock | 16,269 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000286 · stromatt_4.xml · nonDerivative · entry 1 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 21:03 UTC |
Gross Jane ASee Remarks
|
GrantStock Option (right to buy) · Derivative | 33,700 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001019056-17-000232 · gross_4.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,339 Underlying: Common Stock · 33,700 shares Expires 2027-02-24 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 16:04 UTC |
Maddux Randy JoeSenior VP, Operations
|
GrantStock Option (right to buy) · Derivative | 33,700 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001019056-17-000236 · maddux_4.xml · derivative · entry 1 Maddux Randy Joe · CIK 0001683826 · Senior VP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,700 Underlying: Common Stock · 33,700 shares Expires 2027-02-24 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 21:06 UTC |
White Marvin LDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 75,800 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001019056-17-000240 · white_4.xml · derivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,918 Underlying: Common Stock · 75,800 shares Expires 2027-02-24 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 21:05 UTC |
Stromatt Scott CChief Medical Officer and SVP
|
GrantStock Option (right to buy) · Derivative | 33,700 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001019056-17-000238 · stromatt_4.xml · derivative · entry 1 Stromatt Scott C · CIK 0001679975 · Chief Medical Officer and SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,580 Underlying: Common Stock · 33,700 shares Expires 2027-02-24 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 24, 2018. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 21:03 UTC |
Lamothe Jeffrey G.SVP, CFO and Treasurer
|
GrantStock Option (right to buy) · Derivative | 33,700 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001019056-17-000234 · lamothe_4.xml · derivative · entry 1 Lamothe Jeffrey G. · CIK 0001679967 · SVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,232 Underlying: Common Stock · 33,700 shares Expires 2027-02-24 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 24, 2018. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 23:26 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 18,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001019056-17-000109 · gross_4.xml · derivative · entry 3 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,608 Underlying: Common Stock · 18,135 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU converts into the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 3, 2016, the reporting person was granted 36,271 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. F2 · derivative.expiration_date: On August 3, 2016, the reporting person was granted 36,271 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 23:26 UTC |
Gross Jane ASee Remarks
|
Tax withholdingCommon Stock | 5,922 | $1.92 | $11,370.24 |
DisclosureSEC source: 0001019056-17-000109 · gross_4.xml · nonDerivative · entry 2 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,871 Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 23:26 UTC |
Gross Jane ASee Remarks
|
Exercise / conversionCommon Stock | 18,135 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001019056-17-000109 · gross_4.xml · nonDerivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU converts into the Issuer's common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.